CD274 and large cell neuroendocrine carcinoma: Although prospective data regarding use of immune checkpoint in LCNEC is lacking, small studies have evaluated PD-L1 expression and frequency in LCNEC patients, supporting further exploration of immune checkpoint in these patients (17).